pentobarbital will decrease the extent or outcome of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Use of other treatment plans is strongly suggested when linagliptin is to be administered by using a CYP3A4 inducerClients stabilized on corticosteroid therapy may demand dosage changes if barbiturate